GlassScriptPhysician profile
Chiou-Yan Lai
NPI 1801347901
$1,492.60
in general payments reported to CMS, 2019-2025
22 companies · $675 in 2025
The $675 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.60 · 2022: $143 · 2023: $186 · 2024: $390 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $214.13 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $203.62 | 2023-2024 | Repatha, Otezla |
| Abbvie INC. | $146.37 | 2022-2025 | |
| Pfizer INC. | $137.95 | 2021-2025 | |
| Boston Scientific Corporation | $94.09 | 2021-2022 | |
| Glaxosmithkline, LLC. | $93.03 | 2024-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $70.82 | 2024-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $70.49 | 2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $64.86 | 2024-2025 | Airsupra, Breztri |
| Lilly USA, LLC | $60.89 | 2021-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $58.87 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Inspire Medical Systems, INC. | $54.24 | 2024-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.31 | 2024 | Jardiance |
| Aimmune Therapeutics, INC. | $33.29 | 2024-2025 | Zenpep |
| Phathom Pharmaceuticals, INC. | $22.82 | 2025 | Voquezna |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $22.20 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.91 | 2025 | Lifevest |
| Uswm, LLC | $18.78 | 2022 | |
| Phadia US INC. | $15.86 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.88 | 2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $13.86 | 2025 | |
| Cranial Technologies, INC | $13.33 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chiou-Yan Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.